🏛️ Verified NIH Record • Updated 2026-04-06
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis (NCT04844359)
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: National Jewish Health
🩺 Plain-English Summary (8th-Grade Level)
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Who can join: Review the eligibility criteria below.
Location: University of Arizona — Tucson, Arizona
Age range: 18 Years to 85 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- University of Arizona — Tucson, Arizona
- University of California Davis — Sacramento, California
- National Jewish Health — Denver, Colorado
- University of Chicago — Chicago, Illinois
- Mayo Clinic — Rochester, Minnesota
- University of Texas Southwestern — Dallas, Texas
- University of Utah — Salt Lake City, Utah
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypersensitivity Pneumonitis
- Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis — New York, New York
Explore by condition: All Hypersensitivity Pneumonitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.